Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

New 6K

$Genetic Technologies (GENE.US)$ Notice of Delisting from Nasdaq and Failure to Satisfy a Continued Listing Rule or Standard.

Melbourne Australia, December 12, 2024: Genetic Technologies Limited (Administrators Appointed) (ASX: GTG; NASDAQ: GENE) (“Genetic Technologies” or the “Company”) previously announced on November 20, 2024 that Ross Blakeley and Paul Harlond of FTI Consulting had been appointed as Joint and Several Voluntary Administrators (“Administrators”) pursuant to section 436A of the Corporations Act 2001 (Cth), effective immediately.

On December 6, 2024 the Company received written notice (the “Delisting Notice”) from the staff of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the appointment of the Voluntary Administrators and after reviewing disclosures and other publicly available information, and in accordance with Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1, the Staff of Nasdaq had determined that the Company’s securities will be delisted from Nasdaq. Accordingly, trading of the Company’s American Depository Shares (“ADS”) will be suspended at the opening of business on December 17, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (“SEC”), which will remove the Company’s securities from being listed and registration on the Nasdaq Stock Market.

In the Delisting Notice, the Staff of Nasdaq referenced the Voluntary Administration filing and associated public interest concerns raised by it, concerns regarding the residual equity interest of the existing listed securities holders and concerns about the Company’s ability to sustain compliance with all requirements for continued listing on Nasdaq. Specifically, on October 22, 2024, Staff notified the Company that since its shareholders’ equity as of June 30, 2024, was approximately $1,220,704, and the Company did not meet the alternatives of market value of listed securities or net income from continuing operations, the Company no longer complies with our Listing Rule 5550(b). This deficiency serves as an additional and separate basis for delisting.

The Delisting Notice also indicates that the Company may appeal Nasdaq’s determination pursuant to procedures set forth in Nasdaq Listing Rule 5800 Series. The Company’s Administrators have indicated they do not intend to appeal this determination.

The Company notes that, since October 17, 2024 its ADSs have been suspended from trading as a result of trading halts and suspensions of trading in its ordinary securities on its home exchange, Australian Securities Exchange (“ASX”). The decision by Nasdaq to delist the Company’s ADS does not affect the Company’s listing on ASX.

- END –

Authorised for release by the Administrators.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
20
Translate
Report
3504 Views
Comment
Sign in to post a comment

View more comments...